Literature DB >> 34167998

Rhino-orbital mucormycosis in a COVID-19 patient.

Harithraa Cheniappangoundar Baskar1, Aswin Chandran2, Chandra Shekar Reddy1, Shuchita Singh1.   

Abstract

Entities:  

Keywords:  COVID-19; Ear; Nose and throat/otolaryngology; Tropical medicine (infectious disease)

Year:  2021        PMID： 34167998     DOI： 10.1136/bcr-2021-244232

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


× No keyword cloud information.
  9 in total

1.  The perioperative anaesthetic management and outcomes of COVID-19 associated mucormycosis patients.

Authors:  Amuktamalyada Mulakaluri; Shalini Subramanian; P Subramanya Rao; Pushpa Lengade
Journal:  Indian J Anaesth       Date:  2022-05-19

Review 2.  Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.

Authors:  Asim Azhar; Wajihul Hasan Khan; Parvez Anwar Khan; Khaled Alhosaini; Mohammad Owais; Aijaz Ahmad
Journal:  J Infect Public Health       Date:  2022-02-18       Impact factor: 3.718

Review 3.  COVID-19-associated mucormycosis of head-and-neck region: A systematic review.

Authors:  Mamata Kamat; Uma Datar; Sanjay Byakodi; Sharad Kamat; Varsha Vimal Kumar
Journal:  J Clin Transl Res       Date:  2022-01-03

4.  Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.

Authors:  Ameet Dravid; Reema Kashiva; Zafer Khan; Balasaheb Bande; Danish Memon; Aparna Kodre; Milind Mane; Vishal Pawar; Dattatraya Patil; Suraj Kalyani; Prathamesh Raut; Madhura Bapte; Charlotte Saldanha; Dinesh Chandak; Teerthagouda Patil; Sateesh Reddy; Krushnadas Bhayani; Laxmi Suresh; Vishnu Dillibabu; Shipra Srivastava; Shubham Khandelwal; Sailee More; Atif Shakeel; Mohit Pawar; Pranava Nande; Amol Harshe; Sagar Kadam; Sudhir Hallikar; Nudrat Kamal; Danish Andrabi; Sachin Bodhale; Akshay Raut; Sangeeta Chandrashekhar; Chandrashekhar Raman; Uma Mahajan; Gaurav Joshi; Dilip Mane
Journal:  Mycoses       Date:  2022-03-10       Impact factor: 4.931

5.  First Molecular Identification of Three Clinical Isolates of Fungi Causing Mucormycosis in Honduras.

Authors:  Bryan Ortiz; Isis Laínez-Arteaga; Celeste Galindo-Morales; Lilia Acevedo-Almendárez; Kateryn Aguilar; Diana Valladares; Miriam López; Gustavo Fontecha
Journal:  Infect Dis Rep       Date:  2022-04-07

Review 6.  Mucormycosis co-infection in COVID-19 patients: An update.

Authors:  Abdullah S Alkhamiss; Ahmed A Ahmed; Zafar Rasheed; Ruqaih Alghsham; Ali Shariq; Thamir Alsaeed; Sami A Althwab; Suliman Alsagaby; Abdullah S M Aljohani; Fahad A Alhumaydhi; Sharifa K Alduraibi; Alaa K Alduraibi; Homaidan T Alhomaidan; Khaled S Allemailem; Raya A Alharbi; Samar A Alamro; Arwa M Alqusayer; Sahim A Alharbi; Thekra A Alharby; Mona S Almujaydil; Ayman M Mousa; Sultan A Alghaniam; Abdulrhman A Alghunaim; Rana Alghamdi; Nelson Fernández; Waleed Al Abdulmonem
Journal:  Open Life Sci       Date:  2022-08-10       Impact factor: 1.311

7.  Comparative risk assessment of COVID-19 associated mucormycosis and aspergillosis: A systematic review.

Authors:  Prodip Kumar Baral; Md Abdul Aziz; Mohammad Safiqul Islam
Journal:  Health Sci Rep       Date:  2022-08-18

Review 8.  COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic.

Authors:  Pankaj Chandley; Priyanka Subba; Soma Rohatgi
Journal:  Vaccines (Basel)       Date:  2022-08-06

Review 9.  COVID-19 and mucormycosis superinfection: the perfect storm.

Authors:  Jaffar A Al-Tawfiq; Saad Alhumaid; Abeer N Alshukairi; Mohamad-Hani Temsah; Mazin Barry; Abbas Al Mutair; Ali A Rabaan; Awadh Al-Omari; Raghavendra Tirupathi; Manaf AlQahtani; Salma AlBahrani; Kuldeep Dhama
Journal:  Infection       Date:  2021-07-24       Impact factor: 3.553
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.